Core Viewpoint - Ping An Good Doctor (01833) is expected to achieve approximately 15% revenue growth and a net profit margin of about 5% for the full year, with a target price of HKD 14.0, maintaining a "Hold" rating [2]. Financial Performance - In 3Q25, the company reported a revenue increase of 14% year-on-year to RMB 3.72 billion, and a net profit growth of 73% to RMB 180 million, with a net profit margin increase of 1.7 percentage points to 4.9% [3]. - Adjusted net profit for 9M25 grew by 46% to RMB 220 million, with an adjusted net profit margin of 5.8% [3]. - For 3Q25, revenue was up 3% year-on-year to RMB 1.22 billion, while net profit increased by 7% to RMB 48.93 million [3]. Business Segments - The F+B segment saw a revenue increase of 21.5% year-on-year, with over 4,500 corporate clients served [4]. - The number of paid users in the B segment grew by 30.6% year-on-year, and the number of users in home care services increased by 41% compared to the end of 2024 [4]. Management Changes - The appointment of new management, including Guo Xiaotao as Chairman and He Mingke as CEO, is expected to enhance collaboration with the group and drive new business development [5].
浦银国际：维持平安好医生(01833)“持有”评级 目标价14.0港元